University of Bristol
4 stories
-
healthArthritis Drug Shows Promise for Treatment-Resistant Depression
A new study suggests tocilizumab, an anti-inflammatory drug for arthritis, may help patients with depression who don't respond to standard antidepressants.
-
healthImmunotherapy Shows Promise for Treatment-Resistant Depression
A small early trial suggests tocilizumab, an anti-inflammatory drug, may help those with depression not responding to standard antidepressants.
-
healthGLP-1 Drugs Show Heart Attack Recovery Potential
New research reveals Ozempic-like drugs may reduce heart damage after a heart attack by restoring blood flow through capillaries, offering a promising new therapeutic pathway.
-
healthWeight-Loss Drugs Show Promise in Preventing Heart Attack Complications
New research suggests GLP-1 drugs, known for weight loss, could significantly reduce cardiac risks by opening blocked blood vessels after heart attacks.